Inovio Pharmaceuticals
INO
#9821
Rank
HK$0.62 B
Marketcap
HK$7.61
Share price
-4.89%
Change (1 day)
-35.82%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2026 (TTM): -HK$0.69 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -HK$0.71 Billion, an increase over its 2024 earnings that were of -HK$0.84 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.69 Billion-3.76%
2025 -HK$0.71 Billion-15.67%
2024 -HK$0.84 Billion-20.03%
2023 -HK$1.05 Billion-51.56%
2022 -HK$2.17 Billion-8.26%
2021 -HK$2.37 Billion95.4%
2020 -HK$1.21 Billion36.62%
2019 -HK$0.89 Billion20.19%
2018 -HK$0.74 Billion10.94%
2017 -HK$0.67 Billion9.59%
2016 -HK$0.61 Billion118.9%
2015 -HK$0.28 Billion-10.67%
2014 -HK$0.31 Billion83.32%
2013 -HK$0.17 Billion
2011 -HK$0.18 Billion15.64%
2010 -HK$0.16 Billion37.7%
2009 -HK$0.11 Billion2.19%
2008 -HK$0.11 Billion-14.09%
2007 -HK$0.13 Billion19.12%
2006 -HK$0.11 Billion9.62%
2005 -HK$95.47 Million5.77%
2004 -HK$90.26 Million73.08%
2003 -HK$52.15 Million12.75%
2002 -HK$46.26 Million
2000 -HK$70.01 Million53.93%
1999 -HK$45.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$203.71 B-29,892.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$123.76 B-18,200.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$83.04 B-12,245.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$84.12 B-12,402.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$103.13 B-15,182.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$78.50 B-11,580.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-HK$21.59 Million-96.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-HK$1.26 Billion 83.29%๐Ÿ‡บ๐Ÿ‡ธ USA